Chitooligosaccharides Improve the Efficacy of Checkpoint Inhibitors in a Mouse Model of Lung Cancer

YKL-40 (also named chitinase 3 like-1 protein [CHI3L1]) is a secreted chitinase-like protein which is upregulated in cancers and suggested to have pro-tumorigenic activity. YKL-40 lacks enzymatic function, but it can bind carbohydrates such as chitin. Chitooligosaccharides (COS) derived from deacety...

詳細記述

書誌詳細

主要な著者:	Astrid Zedlitz Johansen, Marco Carretta, Marie-Louise Thorseth, Shawez Khan, Klaire Yixin Fjæstad, Christian Beltoft Brøchner, Hannes Linder, Christina Ankjærgaard, Marco Donia, Inna Chen, Dorte Lisbet Nielsen, Claus Preibisch Behrens, Daniel Hargbøl Madsen
フォーマット:	Artigo
言語:	Inglês
出版事項:	MDPI AG 2022-05-01
シリーズ:	Pharmaceutics
主題:	checkpoint inhibitors chitin chitooligosaccharides immunotherapy lung cancer radiotherapy
オンライン･アクセス:	https://www.mdpi.com/1999-4923/14/5/1046
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!